Scifed Global Meeting on Cardiology-2018

Transcatheter aortic valve replacement

Transcatheter aortic valve replacement (TAVR) is also known as Transcatheter aortic valve implantation (TAVI) and percutaneous aortic valve replacement (PAVR). Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace a narrowed aortic valve that fails to open properly. This procedure is fairly new and is FDA approved for people with symptomatic aortic stenosis who are considered an intermediate or high risk patient for standard valve replacement surgery.

Usually valve replacement requires an open heart procedure with a “sternotomy”, in which the chest is surgically separated (open) for the procedure. The TAVR or TAVI procedures can be done through very small openings that leave all the chest bones in place.

A TAVR procedure is not without risks, but it provides beneficial treatment options to people who may not have been candidates for them a few years ago while also providing the added bonus of a faster recovery in most cases. A patient's experience with a TAVR procedure may be comparable to a balloon treatment or even an angiogram in terms of down time and recovery, and will likely require a shorter hospital stay (average 3-5 days).

Possible risks associated with heart valve repair or replacement surgery include: Bleeding during or after the surgery. Blood clots that can cause heart attack, stroke, or lung problems. Arrhythmias (abnormal heart rhythms)

Most commonly, the procedure is performed under “monitored anesthesia care” using intravenous (IV) sedatives and pain medicines as well as local anesthetic and without the need of “breathing tube” or “breathing machine”.  A team of interventional cardiologists, imaging specialists, heart surgeons and cardiac anesthesiologists work together to place the valve and make sure it is working properly.

Cardiology-2018 conference is providing excellent opportunity for the people related to “Transcatheter aortic valve replacement” to meet experts, exchange information, and strengthen the collaboration among Directors, Researchers, Associate Professors, and Scholars from both academia and industry.

For more details, have a glance at PS: http://scientificfederation.com/cardiology-2018/index.php